The role of ThinPrep cytology in the evaluation of estrogen and progesterone receptor content of breast tumors

Surgical Oncology

Volumn 15, Issue 4, 2006, Pages 257-266

  Konofaos, P ^a,b   Kontzoglou, K ^b   Georgoulakis, J ^c   Megalopoulou, T ^d   Zoumpouli, C ^c   Christoni, Z ^c   Papadopoulos, O ^b   Kouraklis, G ^b   Karakitsos, P ^c  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b LAIKO GENERAL HOSPITAL   (Greece)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Breast cancer; Estrogen receptor (ER) and progesterone receptor (PR) content; FNA biopsy; ThinPrep technique

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ASPIRATION BIOPSY; BREAST CARCINOMA; BREAST TUMOR; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING;

ADULT; AGED; BIOPSY, FINE-NEEDLE; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PILOT PROJECTS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 34248668709     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2007.03.004     Document Type: Review

References (56)

1. Borg A., Tandon A.K., Sigurdsson H., et al. HER-2/neu amplification predicts poor survival in node-positive breast cancer. Cancer Research 50 (1990) 4332-4337
2. Harris J., Lippman M., Morrow M., and Osborne C. Diseases of the breast. 2nd edition (1999), Lippincott Williams & Wilkins, Philadelphia
3. Clark G., and McGuire W. Steroid receptors and other prognostic factors in primary breast cancer. Seminars in Oncology 15 (1988) 20-25
4. Aaltomaa S., Lipponen P., Eskelinen M., et al. Prognostic factors after 5 years follow-up in female breast cancer. Oncology 49 (1992) 93-98
5. Auer G.U., Gaspersson T., and Wallgren A.S. DNA content and survival in mammary carcinoma. Analytical and Quantitative Cytology 2 (1980) 161-165
6. Auer G.U., Gaspersson T., Gustafsson S., et al. Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas. Analytical and Quantitative Cytology 2 (1980) 280-284
7. Sachs H., and Winzer J. Histological diagnosis, DNA-content and chromatin pattern of breast cancer cases with positive and negative 17-beta-oestradiol receptor binding. Archiv für Gynakologie 221 (1976) 323-338
8. King W.J., and Greene G.L. Monoclonal antibodies localize estrogen receptor in the nuclei of target cells. Nature 307 5953 (1984) 745-747
9. Yamashita H., Yando Y., Nishio M., Zhang Z., Hamaguchi M., Mita K., et al. Immunohistochemical evaluation of hormone receptor status for predicting response to endocrine therapy in metastatic breast cancer. Breast Cancer 13 1 (2006) 74-83
10. Schmitt F.C., Bento M.J., and Amendoeira I. Estimation of estrogen receptor content in fine-needle aspirates from breast cancer using the monoclonal antibody 1D5 and microwave oven processing: correlation with paraffin embedded and frozen sections determinations. Diagnostic Cytopathology 13 (1995) 347-351
11. Li K.H., Bedard Y.C., and Gan N.C. Fine Needle Aspiration of breast: the ThinPrep: the first year of experience. Acta Cytologica 39 (1995) 1002-1003
12. Powles T.J., Trott P.A., Cherrymann G., et al. Fine Needle Aspiration cytodiagnosis as a pre-requisite for primary medical treatment of breast cancer. Cytopathology 2 (1991) 7-12
13. DeMay R.M. The Art & Science of Cytopathology: Aspiration Cytology. 1st edn (1996), ASCP Press, Chicago, IL
14. Sauer T., Beraki E., Jebsen P.W., et al. Assessing estrogen and progesterone receptor status in fine needle aspirates from breast carcinomas. Results on six years of material and correlation with biochemical assay. Analytical Quantitative Cytology and Histology 20 (1998) 122-126
15. Tafjord S., Bohler P.J., Risberg B., and Torlakovic E. Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry. Diagnostic Cytopathology 26 (2002) 137-141
16. Reiner A., Spona J., Reiner G., Schemper M., Kolb R., Kwasny W., et al. Estrogen receptor analysis on biopsies and fine needle aspirates from human breast carcinoma. American Journal of Pathology 125 (1986) 443-449
17. Makris A., Allred D.C., Powles T.J., Dowsett M., Fernando I.N., Trott P.A., et al. Cytological evaluation of biological prognostic markers from primary breast carcinomas. Breast Cancer Research and Treatment 44 (1997) 65-74
18. Railo M., Nordling S., Krogerus L., Sioris T., and von Smitten K. Preoperative assessment of proliferative activity and hormonal receptor status in carcinoma of the breast: a comparison of needle aspiration and needle-core biopsies to the surgical specimen. Diagnostic Cytopathology 15 (1996) 205-210
19. Biscotti C.V., Shorie J.H., Gramlich T.L., and Easley K.A. ThinPrep vs conventional smear cytologic preparations in analysing fine needle aspiration specimens from palpable breast masses. Diagnostic Cytopathology 21 (1999) 137-141
20. Dey P., Luthra U.K., George J., Zuhairy F., George S.S., and Haji B.I. Comparison of ThinPrep and conventional preparations on fine needle aspiration cytology material. Acta Cytologica 44 (2000) 46-50
21. Zacijek J. Aspiration biopsy cytology. I. Cytology of supra-diaphragmatic organs. In: Wied G.L. (Ed). Monographs of clinical cytology (1974), Karger, Basel
22. Franzen S., and Zajicek J. Aspiration biopsy in diagnosis of palpable lesions of the breast. Critical review of 3479 consecutive biopsies. Acta Radiologica: Therapy, Physics, Biology 7 (1968) 241-262
23. Cytyc. ThinPrep 2000 Operator's Manual (1997), Cytyc, Boxborough, MA
24. Masood S., Fryberg E.R., McLellan G.L., and Bullard J.B. Application of estrogen receptor immunocytochemical assay to aspirates from immunocytochemically guided fine needle biopsy of nonpalpable breast lesions. Southern Medical Journal 84 (1991) 857-861
25. Söderqvist G. Estrogen and progesterone receptor content in breast epithelial cells from healthy women during the menstrual cycle. American Journal of Obstetics and Gynecology 168 (1993) 874-879
26. Tabbara S.O., Sidawy M.K., Frost A.R., Brosky K.R., Coles V., Hecht S., et al. The stability of estrogen and progesterone receptor expression on breast carcinoma cells stored as PreservCyt suspensions and as ThinPrep slides. Cancer 84 (1998) 355-360
27. Page D.L. Prognosis and breast cancer. American Journal of Surgical Pathology 4 (1991) 334-349
28. Masood S. Use of monoclonal antibody for assessment of estrogen receptor contents in fine-needle aspiration biopsy specimen from patients with breast cancer. Archives of Pathology and Laboratory Medicine 113 (1989) 26-30
29. ASCO Tumor Marker Expert Panel. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Journal of Clinical Oncology 1996;14:2843-77.
30. Allred D.C., Harvey J.M., Berardo M.D., et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Modern Pathology 11 (1998) 155-168
31. Harvey J.M., Clark G.M., Osborne C.K., and Allred D.C. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. Journal of Clinical Oncology 17 5 (1999) 1474-1481
32. Clark G.M., Osborne C.K., and McGuire W.L. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. Journal of Clinical Oncology 2 (1984) 1102-1109
33. Clark G.M. Do we really need prognostic factors in breast cancer?. Breast Cancer Research and Treatment 30 (1993) 117-126
34. Clark G.M., Wenger C.R., Beardslee S., et al. How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer. Cancer 71 (1993) 2157-2162
35. Goldhirsch A., Glick J.H., Gelber R.D., Coates A.S., and Senn H.J. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. Journal of Clinical Oncology 19 18 (2001) 3817-3827
36. Marchetti E., Bagni A., Querzoli P., et al. Immunocytochemical detection of estrogen receptors by staining with monoclonal antibodies on cytologic specimens of human breast cancer. Acta Cytologica 32 (1988) 829-834
37. Katz R.L., Patel S., Sneige N., Fritsche Jr. H.A., Hortobagyi G.N., Ames F.C., et al. Comparison of immunocytochemical and biochemical assays for estrogen receptor in fine needle aspirates and histologic sections from breast carcinomas. Breast Cancer Research Treatment 15 (1990) 191-203
38. Keshgegian A.A., Inverso K., and Kline T.S. Determination of estrogen receptor by monoclonal antireceptor antibody in aspiration biopsy cytology from breast carcinoma. American Journal of Clinical Pathology 89 (1988) 24-29
39. Cuthbert A., Herbert A., Coddington R., Theaker J., Taylor I., and Royle G.T. Demonstration of oestrogen receptor in symptomatic breast carcinoma, using fine needle aspiration cytology. Cytopathology 1 6 (1990) 339-347
40. Andersen S., Thorpe S.M., Rose C., Christensen I., Rasmussen B.B., and Poulsen H.S. Estrogen receptor in primary breast cancer estimated in paraffin-embedded tissue. A study of its usefulness compared to dextran-coated charcoal assay. Acta Oncologica 30 6 (1991) 685-690
41. Saccani Jotti G., Johnston S.R., Salter J., Detre S., and Dowsett M. Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay. Journal of Clinical Pathology 47 10 (1994) 900-905
42. Hudock J.A., Hanau C.A., Christen R., and Bibbo M. Expression of estrogen and progesterone receptors in cytologic specimens using various fixatives. Diagnostic Cytopathology 15 1 (1996) 78-83
43. Cano G., Milanezi F., Leitao D., Ricardo S., Brito M.J., and Schmitt F.C. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2. Diagnostic Cytopathology 29 4 (2003) 207-211
44. Nizzoli R., Bozzetti C., Naldi N., Guazzi A., Gabrielli M., Michiara M., et al. Comparison of the results of immunocytochemical assays for biologic variables on preoperative fine-needle aspirates and on surgical specimens of primary breast carcinomas. Cancer 90 1 (2000) 61-66
45. Lofgren L., Skoog L., von Schoultz E., Tani E., Isaksson E., Fernstad R., et al. Hormone receptor status in breast cancer-a comparison between surgical specimens and fine needle aspiration biopsies. Cytopathology 14 3 (2003) 136-142
46. Mander B.J., Heal K., Porushotham A.D., and Wishart G.C. Oestrogen-receptor status in management of breast cancer in UK. Lancet 352 9121 (1998) 36-37
47. Silverman J.F., Finley J.L., O'Brien K.F., et al. Diagnostic accuracy and role of immediate interpretation of fine needle aspiration biopsy specimens from various sites. Acta Cytologica 33 (1989) 791-796
48. Kurtycz D.F., and Hoerl H.D. Thin-layer technology: tempered enthusiasm. Diagnostic Cytopathology 23 (2000) 1-5
49. Dabbs D.J., Abendroth C., Genko R.T., Wang X., and Radcliffe G.E. Immunocytology with ThinPrep ThinLayer slides. Acta Cytologica 40 (1996) 1107A
50. Hall S., Wu T.C., Fields A.L., Sherman M., and Erozan Y. Suitability of ThinPrep specimens for immunocytochemistry and gene amplification by polymerase chain reaction. Acta Cytologica 36 (1992) 585A
51. Leung S.W., and Bedard Y.C. Immunocytochemical staining on ThinPrep processed smears. Modern Pathology 9 (1996) 304-306
52. Leung S.W., and Bedard Y.C. Estrogen and progesterone receptor contents in ThinPrep-processed fine-needle aspirates of breast. American Journal of Clinical Pathology 112 (1999) 50-56
53. Pollett A., Bedard Y.C., Li S.Q., Rohan T., and Kandel R. Correlation of p53 mutations in ThinPrep-processed fine needle breast aspirates with surgically resected breast cancers. Modern Pathology 13 11 (2000) 1173-1179
54. Tisserand P., Fouquet C., Marck V., Mallard C., Fabre M., Vielh P., et al. ThinPrep-processed fine-needle samples of breast are effective material for RNA- and DNA-based molecular diagnosis: application to p53 mutation analysis. Cancer 99 4 (2003) 223-232
55. Bedard Y.C., Pollett A.F., Leung S.W., and O'Malley F.P. Assessment of thin-layer breast aspirates for immunocytochemical evaluation of HER2 status. Acta Cytologica 47 6 (2003) 979-984
56. Beatty B.G., Bryant R., Wang W., Ashikaga T., Gibson P.C., Leiman G., et al. HER-2/neu detection in fine-needle aspirates of breast cancer: fluorescence in situ hybridization and immunocytochemical analysis. American Journal of Clinical Pathology 122 2 (2004) 246-255